Silencing the FGF19 gene using shRNA or neutralizing secreted FGF19 using anti-FGF19 antibodies can significantly inhibit the proliferation of hepatoblastoma cells, with this inhibitory effect being dose-dependent. The gene discussed is FGF19; the disease is hepatoblastoma.